Jean-François Prost
Founder bij GamaMabs Pharma SA
Profiel
Jean-François Prost is the founder of GamaMabs Pharma SA. He is currently the Research & Development Director at UCB Pharma SA (France).
Previously, he worked as the Director-Scientific at LFB Biotechnologies SASU, Laboratoire Français du Fractionnement et des Biotechnologies, and as the Director-Research & Development at Pierre Fabre Médicament Production SAS.
He also served as the Director at rEVO Biologics, Inc. from 2009 to 2010.
From 1998 to 2000, he was the Director-Research & Development at UCB SA.
Actieve functies van Jean-François Prost
Bedrijven | Functie | Begin |
---|---|---|
GamaMabs Pharma SA
GamaMabs Pharma SA Medical/Nursing ServicesHealth Services GamaMabs Pharma SA specializes in developing monoclonal antibodies. It offers research and development solutions for biopharmaceutical industry. The company was founded by Jean-Francois Prost and Stephane Degove in June 2013 and is headquartered in Toulouse, France. | Founder | - |
UCB Pharma SA (France)
UCB Pharma SA (France) Pharmaceuticals: MajorHealth Technology Part of UCB SA, UCB Pharma SA (France) specializes in allergic and respiratory diseases and disorders. The private company is based in Nanterre, France. | Director/Board Member | - |
Eerdere bekende functies van Jean-François Prost
Bedrijven | Functie | Einde |
---|---|---|
REVO BIOLOGICS INC | Director/Board Member | 06-12-2010 |
UCB | Chief Tech/Sci/R&D Officer | 01-01-2000 |
Pierre Fabre Médicament Production SAS
Pierre Fabre Médicament Production SAS Medical SpecialtiesHealth Technology Pierre Fabre Médicament Production SAS engages in the production of pharmaceutical products. It develops in the areas of oncology, ethics, and consumer health care. The company was founded in 1960 and is headquartered in Boulogne Billancourt, France. | Director/Board Member | - |
LFB Biotechnologies SASU
LFB Biotechnologies SASU BiotechnologyHealth Technology LFB Biotechnologies SASU provides plasma-derived medicinal products. The firm undertakes research and development programs in plasma fractions and biotechnologies in the areas of autoimmune diseases and hemostasis disorders. The company was founded on September 21, 2006 and is headquartered in Courtaboeuf, France. | Chief Tech/Sci/R&D Officer | - |
Laboratoire Français du Fractionnement et des Biotechnologies
Laboratoire Français du Fractionnement et des Biotechnologies BiotechnologyHealth Technology Laboratoire Francais du Fractionnement et des Biotechnologies SA provides plasma-derived medicinal products. It undertakes research and development programs in plasma fractions and biotechnologies in the areas of autoimmune diseases and hemostasis disorders. The firm's products include albumin and immunoglobulin. It also offers products for rare pathologies. The company was founded in 1994 and is headquartered in Les Ulis, France. | Chief Tech/Sci/R&D Officer | - |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
Beursgenoteerde bedrijven | 1 |
---|---|
UCB | Health Technology |
Bedrijven in privébezit | 6 |
---|---|
LFB Biotechnologies SASU
LFB Biotechnologies SASU BiotechnologyHealth Technology LFB Biotechnologies SASU provides plasma-derived medicinal products. The firm undertakes research and development programs in plasma fractions and biotechnologies in the areas of autoimmune diseases and hemostasis disorders. The company was founded on September 21, 2006 and is headquartered in Courtaboeuf, France. | Health Technology |
UCB Pharma SA (France)
UCB Pharma SA (France) Pharmaceuticals: MajorHealth Technology Part of UCB SA, UCB Pharma SA (France) specializes in allergic and respiratory diseases and disorders. The private company is based in Nanterre, France. | Health Technology |
Laboratoire Français du Fractionnement et des Biotechnologies
Laboratoire Français du Fractionnement et des Biotechnologies BiotechnologyHealth Technology Laboratoire Francais du Fractionnement et des Biotechnologies SA provides plasma-derived medicinal products. It undertakes research and development programs in plasma fractions and biotechnologies in the areas of autoimmune diseases and hemostasis disorders. The firm's products include albumin and immunoglobulin. It also offers products for rare pathologies. The company was founded in 1994 and is headquartered in Les Ulis, France. | Health Technology |
Pierre Fabre Médicament Production SAS
Pierre Fabre Médicament Production SAS Medical SpecialtiesHealth Technology Pierre Fabre Médicament Production SAS engages in the production of pharmaceutical products. It develops in the areas of oncology, ethics, and consumer health care. The company was founded in 1960 and is headquartered in Boulogne Billancourt, France. | Health Technology |
rEVO Biologics, Inc.
rEVO Biologics, Inc. BiotechnologyHealth Technology rEVO Biologics, Inc. engages in the development and commercialization of specialty therapeutics to address unmet medical needs in patients with rare, life-threatening conditions. Its products include ATryn, which prevents blood clots during and after surgery and childbirth for patients with hereditary antithrombin deficiency. The company was founded in February 1993 and is headquartered in Framingham, MA. | Health Technology |
GamaMabs Pharma SA
GamaMabs Pharma SA Medical/Nursing ServicesHealth Services GamaMabs Pharma SA specializes in developing monoclonal antibodies. It offers research and development solutions for biopharmaceutical industry. The company was founded by Jean-Francois Prost and Stephane Degove in June 2013 and is headquartered in Toulouse, France. | Health Services |